Cancer drug combo study halted after just 3 patients
Disease control
Terminated
This study tested a new drug called CX-072 combined with other cancer treatments for adults with solid tumors or advanced melanoma. The goal was to see if the combination could shrink tumors. However, the study was stopped early and only 3 people took part, so we don't have enoug…
Phase: PHASE2 • Sponsor: CytomX Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC